Biotech Catches Major Premarket Bid Following FDA Approval
03 Abril 2024 - 11:25AM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024